Watch this comprehensive, FREE webinar to learn from your peers about compounded sublingual semaglutide. During this panel session, two PCCA member pharmacists — who are successfully compounding sublingual semaglutide for their patients — will address the common questions many have been asking:
• Clinical approaches
• Marketing strategies
• Corresponding supplements
• And much more
PCCA team members will also join the member speakers to provide guidance on compliance and legal considerations, as well as the use of SubMagna™ SL HMW with semaglutide and other APIs.

Speakers
• Dawn Ipsen, PharmD, FACA, Clark’s Compounding Pharmacy & Kusler’s Compounding Pharmacy
• Peter Koshland, PharmD, Koshland Pharm Custom Compounding
• Gus Bassani, PharmD, PCCA Chief Science Officer
• Ken Barrow, JD, PCCA General Counsel